NEWS: 公告在东京证券交易所JASDAQ标准市场新上市

市场调查报告书

在寡核苷酸治疗药的全球市场分析 (2021年):新型冠状病毒感染疾病 (COVID-19)中的成长和变化 (到2030年)

Oligonucleotide Therapy Global Market Report 2021: COVID 19 Growth And Change to 2030

出版商 The Business Research Company 商品编码 1009556
出版日期 按订单生产 内容资讯 英文 175 Pages
商品交期: 2-10个工作天内
价格
在寡核苷酸治疗药的全球市场分析 (2021年):新型冠状病毒感染疾病 (COVID-19)中的成长和变化 (到2030年) Oligonucleotide Therapy Global Market Report 2021: COVID 19 Growth And Change to 2030
出版日期: 按订单生产内容资讯: 英文 175 Pages
简介

本报告提供全球寡核苷酸治疗药的市场结构、趋势相关分析,市场的主要特征、结构,及整体市场规模、成长率趋势预测,各市场区隔 (各类型、各用途) 及各地区、主要国家详细趋势,主要企业的简介,近几年的主要趋势,今后的市场机会等调查。

目录

第1章 摘要整理

第2章 寡核苷酸治疗药市场特征

第3章 寡核苷酸治疗药市场趋势与策略

第4章 新型冠状病毒感染疾病 (COVID-19)对寡核苷酸治疗药市场的影响

第5章 寡核苷酸治疗药市场:市场规模、成长率

  • 市场规模 (以金额为准,2015年~2020年)
    • 推动市场要素
    • 阻碍市场要素
  • 市场规模 (以金额为准,2020年~2025年,2030年)
    • 推动市场要素
    • 阻碍市场要素

第6章 寡核苷酸治疗药市场:各领域分析

  • 各种类的市场规模 (以金额为准,2015年~2020年/2020年~2025年/2030年)
  • 反义寡核苷酸
  • 核酸适体
  • 其他
  • 各用途的市场规模 (以金额为准,2015年~2020年/2020年~2025年/2030年)
  • 感染疾病
  • 肿瘤
  • 神经退化性疾病
  • 心血管疾病
  • 肾脏病
  • 其他
  • 各终端用户的市场规模 (以金额为准,2015年~2020年/2020年~2025年/2030年)
  • 医院
  • 研究机关

第7章 寡核苷酸治疗药市场:各地区、各国分析

  • 各地区的市场规模 (以金额为准,2015年~2020年/2020年~2025年/2030年)
  • 各国市场规模 (以金额为准,2015年~2020年/2020年~2025年/2030年)

第8章 亚太地区的寡核苷酸治疗药市场

  • 市场概要
  • 地区资讯
  • 各种类的市场规模 (以金额为准,2015年~2020年/2020年~2025年/2030年)
  • 各用途的市场规模 (以金额为准,2015年~2020年/2020年~2025年/2030年)

第9章 中国市场

第10章 印度市场

第11章 日本市场

第12章 澳洲市场

第13章 印尼市场

第14章 韩国市场

第15章 西欧的寡核苷酸治疗药市场

第16章 英国市场

第17章 德国市场

第18章 法国市场

第19章 东欧的寡核苷酸治疗药市场

第20章 俄罗斯市场

第21章 北美的寡核苷酸治疗药市场

第22章 美国市场

第23章 南美的寡核苷酸治疗药市场

第24章 巴西市场

第25章 中东的寡核苷酸治疗药市场

第26章 非洲的寡核苷酸治疗药市场

第27章 寡核苷酸治疗药市场:竞争情形和企业简介

  • 竞争情形
  • 企业简介
    • Alnylam Pharmaceuticals Inc.
    • Biogen Inc.
    • Dynavax Technologies Corp.
    • Ionis Pharmaceuticals Inc.
    • Merck & Co. Inc.

第28章 寡核苷酸治疗药的开发中产品分析

第29章 寡核苷酸治疗药市场上主要企业合并、收购 (M&A)

第30章 寡核苷酸治疗药市场:未来展望与潜在力分析

第31章 附录

目录

Oligonucleotide Therapy Global Market Report 2021: COVID 19 Growth And Change to 2030 from The Business Research Company provides the strategists, marketers and senior management with the critical information they need to assess the global oligonucleotide therapy market.

This report focuses on oligonucleotide therapy market which is experiencing strong growth. The report gives a guide to the oligonucleotide therapy market which will be shaping and changing our lives over the next ten years and beyond, including the markets response to the challenge of the global pandemic.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 12+ geographies.
  • Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market research findings.
  • Benchmark performance against key competitors.
  • Utilize the relationships between key data sets for superior strategizing.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order.

Where is the largest and fastest growing market for the oligonucleotide therapy? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The Oligonucleotide Therapy market global report from The Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography. It places the market within the context of the wider oligonucleotide therapy market, and compares it with other markets.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, the influence of the Covid 19 virus and forecasting its growth.
  • Market segmentations break down market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of Covid 19 for all regions, key developed countries and major emerging markets.
  • Competitive landscape gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
  • The oligonucleotide therapy market section of the report gives context. It compares the oligonucleotide therapy market with other segments of the oligonucleotide therapy market by size and growth, historic and forecast. It analyses GDP proportion, expenditure per capita, oligonucleotide therapy indicators comparison.

Scope

Markets Covered: 1) By Type: Antisense Oligonucleotide; Aptamer; Other

2) By Application: Infectious Diseases; Oncology; Neurodegenerative Disorders; Cardiovascular Diseases; Kidney Diseases; Others

3) By End User: Hospitals; Research Institutes

Companies Mentioned: Alnylam Pharmaceuticals Inc.; Biogen Inc.; Dynavax Technologies Corp.; Ionis Pharmaceuticals Inc.; Merck & Co. Inc.

Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA

Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa

Time series: Five years historic and ten years forecast.

Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,

Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Table of Contents

1. Executive Summary

2. Oligonucleotide Therapy Market Characteristics

3. Oligonucleotide Therapy Market Trends And Strategies

4. Impact Of COVID-19 On Oligonucleotide Therapy

5. Oligonucleotide Therapy Market Size And Growth

  • 5.1. Global Oligonucleotide Therapy Historic Market, 2015-2020, $ Billion
    • 5.1.1. Drivers Of The Market
    • 5.1.2. Restraints On The Market
  • 5.2. Global Oligonucleotide Therapy Forecast Market, 2020-2025F, 2030F, $ Billion
    • 5.2.1. Drivers Of The Market
    • 5.2.2. Restraints On the Market

6. Oligonucleotide Therapy Market Segmentation

  • 6.1. Global Oligonucleotide Therapy Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Antisense Oligonucleotide
  • Aptamer
  • Other
  • 6.2. Global Oligonucleotide Therapy Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Infectious Diseases
  • Oncology
  • Neurodegenerative Disorders
  • Cardiovascular Diseases
  • Kidney Diseases
  • Others
  • 6.3. Global Oligonucleotide Therapy Market, Segmentation By End User, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Hospitals
  • Research Institutes

7. Oligonucleotide Therapy Market Regional And Country Analysis

  • 7.1. Global Oligonucleotide Therapy Market, Split By Region, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 7.2. Global Oligonucleotide Therapy Market, Split By Country, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

8. Asia-Pacific Oligonucleotide Therapy Market

  • 8.1. Asia-Pacific Oligonucleotide Therapy Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Oligonucleotide Therapy Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 8.3. Asia-Pacific Oligonucleotide Therapy Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

9. China Oligonucleotide Therapy Market

  • 9.1. China Oligonucleotide Therapy Market Overview
  • 9.2. China Oligonucleotide Therapy Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F,$ Billion
  • 9.3. China Oligonucleotide Therapy Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F,$ Billion

10. India Oligonucleotide Therapy Market

  • 10.1. India Oligonucleotide Therapy Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 10.2. India Oligonucleotide Therapy Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

11. Japan Oligonucleotide Therapy Market

  • 11.1. Japan Oligonucleotide Therapy Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 11.2. Japan Oligonucleotide Therapy Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

12. Australia Oligonucleotide Therapy Market

  • 12.1. Australia Oligonucleotide Therapy Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 12.2. Australia Oligonucleotide Therapy Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

13. Indonesia Oligonucleotide Therapy Market

  • 13.1. Indonesia Oligonucleotide Therapy Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 13.2. Indonesia Oligonucleotide Therapy Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

14. South Korea Oligonucleotide Therapy Market

  • 14.1. South Korea Oligonucleotide Therapy Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 14.2. South Korea Oligonucleotide Therapy Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

15. Western Europe Oligonucleotide Therapy Market

  • 15.1. Western Europe Oligonucleotide Therapy Market Overview
  • 15.2. Western Europe Oligonucleotide Therapy Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 15.3. Western Europe Oligonucleotide Therapy Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

16. UK Oligonucleotide Therapy Market

  • 16.1. UK Oligonucleotide Therapy Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 16.2. UK Oligonucleotide Therapy Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

17. Germany Oligonucleotide Therapy Market

  • 17.1. Germany Oligonucleotide Therapy Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 17.2. Germany Oligonucleotide Therapy Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

18. France Oligonucleotide Therapy Market

  • 18.4. France Oligonucleotide Therapy Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 18.5. France Oligonucleotide Therapy Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

19. Eastern Europe Oligonucleotide Therapy Market

  • 19.1. Eastern Europe Oligonucleotide Therapy Market Overview
  • 19.2. Eastern Europe Oligonucleotide Therapy Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 19.3. Eastern Europe Oligonucleotide Therapy Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

20. Russia Oligonucleotide Therapy Market

  • 20.1. Russia Oligonucleotide Therapy Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 20.2. Russia Oligonucleotide Therapy Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

21. North America Oligonucleotide Therapy Market

  • 21.1. North America Oligonucleotide Therapy Market Overview
  • 21.2. North America Oligonucleotide Therapy Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 21.3. North America Oligonucleotide Therapy Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

22. USA Oligonucleotide Therapy Market

  • 22.1. USA Oligonucleotide Therapy Market Overview
  • 22.2. USA Oligonucleotide Therapy Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 22.3. USA Oligonucleotide Therapy Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

23. South America Oligonucleotide Therapy Market

  • 23.1. South America Oligonucleotide Therapy Market Overview
  • 23.2. South America Oligonucleotide Therapy Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 23.3. South America Oligonucleotide Therapy Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

24. Brazil Oligonucleotide Therapy Market

  • 24.1. Brazil Oligonucleotide Therapy Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 24.2. Brazil Oligonucleotide Therapy Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

25. Middle East Oligonucleotide Therapy Market

  • 25.1. Middle East Oligonucleotide Therapy Market Overview
  • 25.2. Middle East Oligonucleotide Therapy Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 25.3. Middle East Oligonucleotide Therapy Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

26. Africa Oligonucleotide Therapy Market

  • 26.1. Africa Oligonucleotide Therapy Market Overview
  • 26.2. Africa Oligonucleotide Therapy Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 26.3. Africa Oligonucleotide Therapy Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

27. Oligonucleotide Therapy Market Competitive Landscape And Company Profiles

  • 27.1. Oligonucleotide Therapy Market Competitive Landscape
  • 27.2. Oligonucleotide Therapy Market Company Profiles
    • 27.2.1. Alnylam Pharmaceuticals Inc.
      • 27.2.1.1. Overview
      • 27.2.1.2. Products and Services
      • 27.2.1.3. Strategy
      • 27.2.1.4. Financial Performance
    • 27.2.2. Biogen Inc.
      • 27.2.2.1. Overview
      • 27.2.2.2. Products and Services
      • 27.2.2.3. Strategy
      • 27.2.2.4. Financial Performance
    • 27.2.3. Dynavax Technologies Corp.
      • 27.2.3.1. Overview
      • 27.2.3.2. Products and Services
      • 27.2.3.3. Strategy
      • 27.2.3.4. Financial Performance
    • 27.2.4. Ionis Pharmaceuticals Inc.
      • 27.2.4.1. Overview
      • 27.2.4.2. Products and Services
      • 27.2.4.3. Strategy
      • 27.2.4.4. Financial Performance
    • 27.2.5. Merck & Co. Inc.
      • 27.2.5.1. Overview
      • 27.2.5.2. Products and Services
      • 27.2.5.3. Strategy
      • 27.2.5.4. Financial Performance

28. Oligonucleotide Therapy Pipeline Analysis

29. Key Mergers And Acquisitions In The Oligonucleotide Therapy Market

30. Oligonucleotide Therapy Market Future Outlook and Potential Analysis

31. Appendix

  • 31.1. Abbreviations
  • 31.2. Currencies
  • 31.3. Research Inquiries
  • 31.4. The Business Research Company
  • 31.5. Copyright And Disclaimer